SHAUNDRECA LOVE: Open Payments
NPI 1447808118 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$875 in 47 payments from 12 companies in 2025. Trend: 2023 $88 · 2024 $444 · 2025 $875
Food & beverage: $875
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 11 | $211 |
| Supernus Pharmaceuticals, Inc. | 10 | $181 |
| ABBVIE INC. | 6 | $104 |
| Vanda Pharmaceuticals Inc. | 5 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Lundbeck LLC | 2 | $45 |
| Tris Pharma Inc | 2 | $41 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
Products named: Auvelity, Qelbree, VRAYLAR, FANAPT, REXULTI, CAPLYTA, Dyanavel XR, Jornay PM.
Industry payments across LA — which companies pay providers there.
